Covid-19 roundup: Re­searchers call out Gilead for di­ver­si­ty of remde­sivir tri­als in NE­JM; Mex­i­co in vac­cine dose, tri­al talks

Racial and eth­nic mi­nor­i­ty groups suf­fer high­er rates of Covid-19 in­fec­tion, hos­pi­tal­iza­tion and death than white or non-His­pan­ic Amer­i­cans.

Yet when remde­sivir was test­ed in …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER